3-deazaneplanocin has been researched along with Hemorrhagic Fever, Ebola in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Smith, A | 1 |
| Bray, M; Driscoll, J; Huggins, JW | 1 |
| Baker, RO; Bray, M; Geisbert, T; Raymond, JL | 1 |
3 other study(ies) available for 3-deazaneplanocin and Hemorrhagic Fever, Ebola
| Article | Year |
|---|---|
l-like 3-deazaneplanocin analogues: Synthesis and antiviral properties.
Topics: Adenosine; Antiviral Agents; Arenaviridae; Arenaviridae Infections; Ebolavirus; Hemorrhagic Fever, Ebola; Humans; Molecular Structure | 2019 |
Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor.
Topics: Adenosine; Adenosylhomocysteinase; Animals; Antiviral Agents; Cell Line; Dose-Response Relationship, Drug; Ebolavirus; Enzyme Inhibitors; Female; Hemorrhagic Fever, Ebola; Hydrolases; Mice; Mice, Inbred BALB C; Mice, SCID; S-Adenosylhomocysteine; Tubercidin | 2000 |
3-deazaneplanocin A induces massively increased interferon-alpha production in Ebola virus-infected mice.
Topics: Adenosine; Animals; Disease Models, Animal; Ebolavirus; Female; Hemorrhagic Fever, Ebola; Immunohistochemistry; Interferon-alpha; Liver; Mice; Mice, Inbred BALB C; Viremia | 2002 |